Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

Arkley Biotek LLC
Profile last edited on: 7/14/20      CAGE: 5FK03      UEI: V4WWG1MLYNY5

Business Identifier: Blood-based diagnostics for early detection of Alzheimer's disease
Year Founded
2005
First Award
2015
Latest Award
2017
Program Status
Inactive
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

4444 Decatur Boulevard Suite 300
Indianapolis, IN 46241
   (317) 641-2838
   N/A
   www.arkleybiotek.com
Location: Single
Congr. District: 07
County: Marion

Public Profile

Arkley Biotek LLC is developing blood-based diagnostics for early detection of Alzheimer's disease. The company plans to use redox-reactive autoantibodies (R-RAA) as an early non-invasive marker for Alzheimer's disease in patients suffering from Mild Cognitive Impairment.

Extent of SBIR involvement

User Avatar
Phase I Awards
1
Phase II Awards
1
Conversion Rate
100.00%
Phase I Dollars
$621,019
Phase II Dollars
$1,144,907
Total Awarded
$1,765,926

Synopsis: Awardee Business Condition

Employee Range
5-9
Revenue Range
.5M-1M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
1-4

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2017 2 NIH $1,765,926
Project Title: Commercialization of a Serum Diagnostic for Detection of Alzheimer's Disease

Key People / Management

  Paul Andrew Hyslop -- Founder and General Manager

Company News

There are no news available.